Exenatide challenge in oral glucose tolerance test is insufficient for predictions of glucose metabolism and insulin secretion after sleeve gastrectomy (SG) in obese patients with type 2 diabetes: a pilot study to establish a preoperative model to estimate β-cell function following augmented glucagon-like peptide-1 secretion after SG-Reference-Cited by-同舟云学术

Exenatide challenge in oral glucose tolerance test is insufficient for predictions of glucose metabolism and insulin secretion after sleeve gastrectomy (SG) in obese patients with type 2 diabetes: a pilot study to establish a preoperative model to estimate β-cell function following augmented glucagon-like peptide-1 secretion after SG

Published:2022 Issue:12 Volume:69 Page:1457-1465
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Nakamura Yuta¹,Horie Ichiro¹^ORCID,Kanetaka Kengo²,Eguchi Susumu²,Nakamichi Seiko³,Hongo Ryoko⁴,Takashima Miwa⁵,Kawakami Atsushi¹,Abiru Norio¹

Affiliation:

1. Department of Endocrinology and Metabolism, Division of Advanced Preventive Medical Sciences, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan

2. Department of Surgery, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan

3. Department of General Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan

4. Department of Nutrition Science, Faculty of Nursing and Nutrition, University of Nagasaki, Nagasaki 851-2195, Japan

5. Nutritional Management Division, Nagasaki University Hospital, Nagasaki 852-8501, Japan

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/69/12/69_EJ22-0224/_pdf

Reference22 articles.

1. 1 Angrisani L, Santonicola A, Iovino P, Vitiello A, Higa K, et al. (2018) IFSO Worldwide Survey 2016: primary, endoluminal, and revisional procedures. Obes Surg 28: 3783–3794.

2. 2 Nannipieri M, Baldi S, Mari A, Colligiani D, Guarino D, et al. (2013) Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones. J Clin Endocrinol Metab 98: 4391–4399.

3. 3 Peterli R, Steinert RE, Woelnerhanssen B, Peters T, Christoffel-Courtin C, et al. (2012) Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obes Surg 22: 740–748.

4. 4 Rubino F, Gagner M (2002) Potential of surgery for curing type 2 diabetes mellitus. Ann Surg 236: 554–559.

5. 5 Casajoana A, Pujol J, Garcia A, Elvira J, Virgili N, et al. (2017) Predictive value of gut peptides in T2D remission: randomized controlled trial comparing metabolic gastric bypass, sleeve gastrectomy and greater curvature plication. Obes Surg 27: 2235–2245.